Efficiency of MY09/11 consensus PCR in the detection of multiple HPV infections

Diagnostic Microbiology and Infectious Disease

Volumn 80, Issue 1, 2014, Pages 43-49

  Şahiner, Fatih ^a   Kubar, Ayhan ^a   Gümral, Ramazan ^a   Ardiç, Medine ^b   Yiğit, Nuri ^a   Şener, Kenan ^a   Dede, Murat ^a   Yapar, Mehmet ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Cervical smear; Genotyping; Mismatches; Type distribution

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; INTERMETHOD COMPARISON; LOW RISK POPULATION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS ISOLATION; WART VIRUS; ADOLESCENT; ADULT; AGED; CLASSIFICATION; GENETICS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVIX; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVIX UTERI; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL DYSPLASIA; YOUNG ADULT;

EID: 84926227407     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.03.030     Document Type: Article

References (32)

1. Bachtiary B., Obermair A., Dreier B., Birner P., Breitenecker G., Knocke T.H., Selzer E., Pötter R. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 2002, 102(3):237-243.
2. Bauer H.M., Greer C.E., Manos M.M. Determination of genital HPV infection using consensus PCR. Diagnostic molecular pathology: a practical approach 1992, 131-152. Oxford University Press, Oxford. C.S. Herrington, J.O.'.D. McGee (Eds.).
3. Chaturvedi A.K., Katki H.A., Hildesheim A., Rodríguez A.C., Quint W., Schiffman M., Van Doorn L.J., Porras C., Wacholder S., Gonzalez P., Sherman M.E. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011, 203(7):910-920.
4. Conway M.J., Meyers C. Replication and assembly of human papillomaviruses. J Dent Res 2009, 88(4):307-317.
5. Coutlée F., Rouleau D., Petignat P., Ghattas G., Kornegay J.R., Schlag P., Boyle S., Hankins C., Vézina S., Coté P., Macleod J., Voyer H., Forest P., Walmsley S. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol 2006, 44(6):1998-2006.
6. Dalstein V., Riethmuller D., Prétet J.L., Le Bail Carval K., Sautière J.L., Carbillet J.P., Kantelip B., Schaal J.P., Mougin C. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003, 106(3):396-403.
7. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., Bosch F.X. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7(7):453-459.
8. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324(1):17-27.
9. Depuydt C.E., Boulet G.A., Horvath C.A., Benoy I.H., Vereecken A.J., Bogers J.J. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 2007, 11(4):881-891.
10. Dictor M., Warenholt J. Single-tube multiplex PCR using type-specific E6/E7 primers and capillary electrophoresis genotypes 21 human papillomaviruses in neoplasia. Infect Agent Cancer 2011, 6(1):1.
11. Ergünay K., Misirlioğlu M., Firat P., Tuncer Z.S., Tuncer S., Yildiz I., Ustaçelebi S. Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities. Mikrobiyol Bul 2008, 42(2):273-282.
12. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlée F., Hildesheim A., Schiffman M.H., Scott D.R., Apple R.J. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000, 38(1):357-361.
13. Gravitt P.E., Viscidi R.P. Measurement of exposure to human papillomaviruses (Chapter 5). Cervical Cancer: From Etiology to Prevention (Cancer Prevention-Cancer Causes) 2004, 119-141. Kluwer Academic Publishers, Boston. T.E. Rohan, K.V. Shah (Eds.).
14. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174.
15. Lee J.H., Lee N.W., Hong S.W., Nam Y.S., Choi J.W., Kim Y.S. Establishment of an efficient multiplex real-time PCR assay for human papillomavirus genotyping in cervical cytology specimens: comparison with hybrid capture II. Cytopathology 2011, 22(4):261-268.
16. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 1989, 7:209-214.
17. Molano M., Van den Brule A., Plummer M., Weiderpass E., Posso H., Arslan A., Meijer C.J., Muñoz N., Franceschi S., HPV Study Group Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol 2003, 158(5):486-494.
18. Molijn A., Kleter B., Quint W., van Doorn L.J. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005, 32(Suppl. 1):S43-S51.
19. Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527.
20. Nindl I., Rindfleisch K., Lotz B., Schneider A., Dürst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 1999, 82(2):203-207.
21. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., Burk R.D. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997, 35(6):1304-1310.
22. Sabol I., Salakova M., Smahelova J., Pawlita M., Schmitt M., Gasperov N.M., Grce M., Tachezy R. Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J Clin Microbiol 2008, 46(5):1606-1613.
23. Sachse K. Specificity and performance of diagnostic PCR assays. PCR Detection of Microbial Pathogens: Methods and Protocols 2003, 3-29. Humana Press Inc., Totowa. K. Sachse, J. Frey (Eds.).
24. Sambrook J., Fritsch E.F., Maniatis T. Isolation of DNA from mammalian cells. Molecular Cloning: A Laboratory Manual 1989, vol. 1:9.16-9.19. Cold Spring Harbor Laboratory Press, New York. 2nd ed. J. Sambrook, E.F. Fritsch, T. Maniatis (Eds.).
25. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., Raab S., Sherman M., Wilbur D., Wright T., Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119.
26. Stevens M.P., Rudland E., Garland S.M., Tabrizi S.N. Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol 2006, 44(7):2428-2433.
27. Şahiner F., Gümral R., Şener K., Yiğit N., Dede M., Yapar M., Kubar A. Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR. Mikrobiyol Bul 2012, 46(4):624-636.
28. Şahiner F., Kubar A., Yapar M., Şener K., Dede M., Gümral R. Detection of major HPVs by a new multiplex real-time PCR assay using type-specific primers. J Microbiol Methods 2014, 97:44-50.
29. Trottier H., Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(Suppl. 1):S1-S15.
30. van Alewijk D., Kleter B., Vent M., Delroisse J.M., de Koning M., van Doorn L.J., Quint W., Colau B. A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay. J Clin Microbiol 2013, 51(4):1171-1178.
31. Yapar M., Aydogan H., Pahsa A., Besirbellioglu B.A., Bodur H., Basustaoglu A.C., Guney C., Avci I.Y., Sener K., Setteh M.H., Kubar A. Rapid and quantitative detection of Crimean-Congo haemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn J Infect Dis 2005, 58:358-362.
32. zur Hausen H. Roots and perspectives of contemporary papillomavirus research. J Cancer Res Clin Oncol 1996, 122(1):3-13.